Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-12-24

Clinical Trial Update: Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial update assessing safety and efficacy of vilazodone in adolescents with major depressive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vilazodone (vilazodone)

Snippet

Sponsor: Forest Laboratories | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2019-12-24